Resources

4 Resources for

trial result

  • Subscribe to this listing via:
  • RSS
  • Email

BNET Resources

Schering-Plough Now in the Feds' Crosshairs
Schering-Plough Now in the Feds' CrosshairsThe Great Disappointment of EthicsPublished on www.brainblogger.com:A Failed Attempt to Improve Misperceived Greatness: The ENHANCE TrialWhile it seems that pharmaceutical company sponsors of clinical trials usually end up with results that clearly favor their meds studied in their trial, there are rare exceptions, and...
Tags: ENHANCE Trial, Schering, Schering-Plough Corp., trial result, Vytorin, Zocor, Merck & Co. Inc.
Discussion threads 2008-07-10
How Pharma Stacks the Deck with Medical Journals
How Pharma Stacks the Deck with Medical JournalsStatistical GymnasticsPublished on www.brainblogger.com:A Failed Attempt to Improve Misperceived Greatness: The ENHANCE TrialWhile it seems that pharmaceutical company sponsors of clinical trials usually end up with results that clearly favor their meds studied in their trial, there are rare exceptions, and Merck...
Tags: ENHANCE Trial, Schering, trial result, Vytorin, Zocor
Discussion threads 2008-06-18
GLAXOSMITHKLINE (GSK).
GlaxoSmithKline's GSK cervical cancer vaccine, Cervarix, may have the edge over US rival Merck's product Gardasil, according to trial results presented this week in America. GlaxoSmithKline's GSK cervical cancer vaccine, Cervarix, may have the edge over US rival Merck's product Gardasil, according...
Tags: GlaxoSmithKline Plc., trial result
Research articles 2006-03-03
Merck's Zocor Suffered Blow When Clinical Trial Went Bad, but Most Engaged Healthy Heart Patients Have Not Yet Backlashed
Despite damaging results from a recent clinical trial on Merck's popular heart medication Zocor, the percentage of negative discussion posts about the drug by thousands of highly engaged consumers across dozens of leading cardiovascular Web sites has actually decreased 45 percent in the two weeks following the trial results. According...
Tags: clinical trial, Merck & Co. Inc., trial result
Research articles 2004-09-27

Additional Resources

Human Genome, Glaxo Lupus Drug Works in 2nd Trial
By Toni Clarke and Ben HirschlerBOSTON/LONDON (Reuters) - Human Genome Sciences Inc said its experimental lupus drug Benlysta was successful in a second large clinical trial, paving the way for approval of the first new treatment for the disease in 50 years.Shares in Human Genome jumped 40 percent in pre-market...
Tags: Genome, Patient, Trial, Benlysta, Clinical Trial, Human, Lupus Research Institute, Us
News items 2009-11-02
DTN News: A Terrorist Trial In New York City
DTN News: A Terrorist Trial In New York City *Source: By Ben West and Fred Burton STRATFOR NSI News Source Info NEW DELHI, India - November 19, 2009: U.S. Attorney General Eric Holder announced Nov. 13 that the U.S. Justice Department had decided to try five...
Tags: Attack, New York, Trial, Courthouse
News items 2009-11-19
Insignia Wins Ruling v. News America; Stage Set for Another Antitrust Trial in POP Biz
Insignia Systems won a ruling in Minnesota federal court paving the way for a full-blown trial on its claims that News America Marketing engaged in unlawful monopoly tactics to deprive it of customers. The issues at stake are largely similar to those in a Michigan state court case in which...
Tags: Advertisement, Antitrust, Compliance, Sara Lee Corp., FLOORgraphics Inc., NAM, Insignia POPSigns, Sales Strategy, Sales, Jim Edwards
Blog posts 2009-10-01
Tom Petters Goes To Trial In History's Second-Largest Hedge Fund Ponzi Scheme
Ed's Note: An earlier version of this article incorrectly stated that Fingerhut had filed for bankruptcy protection. That correction has been made. In Minnesota this week, a trial is quietly getting underway to prosecute the alleged mastermind behind the second largest Ponzi scheme in history....
Tags: Hedge Fund, Trial, Fraud, Ed, Tom Petters, Business Owner, Litigation, Investment, Retail, Financial Services, Business Operations, Finance, Daniel M. Harrison
Blog posts 2009-10-27
Xcyte Therapies, Inc. Announces Withdrawal Of Protocol for Phase II/III Clinical Trial in Chronic Lymphocytic Leukemia and Potential Delay in Trial Initiation
SEATTLE -- Xcyte Therapies, Inc. ("Xcyte", the "Company") (Nasdaq:XCYT) announced today that it has withdrawn its submission to the FDA of the clinical protocol for a planned Phase II/III trial of Xcellerated T Cells in chronic lymphocytic leukemia. The FDA requested the withdrawal to allow additional discussion of the design...
Tags: FDA
Research articles 2005-02-02
Ex-NY mayor says 'America won' in Moussaoui trial
WASHINGTON AFP — Former New York mayor Rudy Giuliani said he disagreed with a jury's decision to spare the life of Al-Qaeda plotter Zacarias Moussaoui but said "America won" from the trial. Giuliani, who testified last month in the sentencing trial to recount his horrific memories of September 11,...
Tags: Agence France-Presse, America, Government, HARDWARE, Washington
Research articles 2006-05-03
Haughey Trial Postponed; Harney Remarks Blamed
Irish Voice 07-04-2000 Haughey Trial Postponed; Harney Remarks Blamed THE Tanaiste (Deputy Prin???e Minister) Mary Harney has found herself at the center of another controversy since the Circuit Court indefinitely postponed the criminal trial of former Taoiseach Prime Minister Charles Haughey...
Tags: Government, Leadership, SOFTWARE, U.S. Circuit Court
Research articles 2000-07-04
Spears, Federline set for custody trial: lawyer
LOS ANGELES AFP — Britney Spears and Kevin Federline's custody dispute looks set to head to trial in August after the couple failed to reach agreement in mediation, it was reported on Friday. Federline's lawyer Mark Vincent Kaplan told the E! Online website that although day-long talks between lawyers...
Tags: Agence France-Presse, agreement, Kaplan, lawyer, Litigation, mediation
Research articles 2008-06-27
Novoste to Increase Enrollment in Beta-Cath System Trial
NORCROSS, Ga.--BW HealthWire--March 12, 1999-- START Trial on Schedule for Enrollment Completion Novoste Corporation (Nasdaq:NOVT) announced today that it is on track to complete enrollment of 1,100 patients into the Beta-CathTM System Trial by the end of this month. However, the Company now plans to increase...
Tags: Novoste Corp.
Research articles 1999-03-12
Kinleys - Captivate increases brand awareness and product trial
This case study emphasis on Increase brand awareness and trial amongst young, urban professionals . With limited resources, the Kilkenny marketing team needed a highly targeted and creative approach to reach their objectives. They decided on a marketing program with two distinct elements: A unique, humorous advertising creative campaign...
Tags: Brand, Brand Awareness, Branding, Marketing
Case studies 2003-01-01
Recruiting Pregnant Smokers for a Placebo-Randomized Controlled Trial of Nicotine Replacement Therapy
This white paper study is aimed to determine the feasibility of recruiting women to a RCT of NRT in pregnancy as they attend hospital antenatal ultrasound examinations, the proportion of such women who are eligible for and interested in trial enrolment and research staff perceptions of how one method of...
Tags: Women, BioMed Central, Recruiting, Therapy, Nicotine Replacement Therapy, Gender And Diversity, Recruitment & Selection, Human Resources, Workforce Management
White papers 2004-11-01
Early Trial Set in OraSure Patent Infringement Lawsuit Against Schering-Plough
BETHLEHEM, Pa. -- OraSure Technologies, Inc. (Nasdaq NM:OSUR) today announced that an early trial has been set in the Company's patent infringement lawsuit filed against Schering-Plough Healthcare Products, Inc. (NYSE:SGP). As a result, a final trial on the merits in this matter is expected to occur in February 2005.
Tags: Schering-Plough Corp.
Research articles 2004-09-28
Free Radical Scavenger Formula Demonstrates Enhanced Athletic Performance in Independent Pepperdine University Clinical Trial
SANTA BARBARA, Calif. -- A clinical trial conducted by Pepperdine University revealed a dramatic improvement in time trial performance by elite cyclists as a result of the daily intake of FRS Plus, a breakthrough Free Radical Scavenger antioxidant supplement beverage. The researchers concluded that FRS Plus significantly boosted peak performance...
Tags: clinical trial, Pepperdine University
Research articles 2004-10-13
Xanthus Completes Special Protocol Assessment with FDA for Phase 3 Registration Trial of Xanafide in Patients with Secondary Acute Myeloid Leukemia
CAMBRIDGE, Mass. -- Xanthus Pharmaceuticals, Inc., today announced that it has reached an agreement with the U.S. Food and Drug Administration FDA under the FDA's Special Protocol Assessment SPA process for the design of its planned Phase 3 registration trial of Xanafide([R])amonafide malate for the treatment of patients with secondary...
Tags: FDA, patient
Research articles 2007-06-12
Lockerbie trial was a CIA fix, US intelligence insider claims PAN AM
THE CIA manipulated the Lockerbie trial and lied about the strength of the prosecution case to get a result that was politically convenient for America, according to a former US State Department lawyer. Michael Scharf, who was the counsel to the US counter-terrorism bureau when the two Libyans...
Tags: CIA, Government, Libya, U.S. Department of State
Research articles 2006-11-12
Questions follow reports of stem cell diabetes cure.
Byline: Peter Aldhous Apr 25, 2007 (New Scientist - ABIX via COMTEX) -- People with type 1 diabetes who took part in a medical trial in Brazil were able to forgo insulin injections for months. Despite media claims to the contrary, it is not...
Tags: stem-cell, Yale University
Research articles 2007-04-25
  • << Previous
  • page 1 of 1
  • Next >>